Nintedanib + Ketoconazole Interaction
Unknowninteraction on record
Description
Coadministration with oral doses of a P-gp and CYP3A4 inhibitor, ketoconazole, increased exposure to nintedanib by 60%.
Source: FDA drug label - nintedanib
Coadministration with oral doses of a P-gp and CYP3A4 inhibitor, ketoconazole, increased exposure to nintedanib by 60%.
Source: FDA drug label - nintedanib